Sign in

CIK 0001377121 · Large accelerated filer

Protagonist Therapeutics, Inc

Sign in to watch
Ticker
PTGX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
980505495
Phone
(510) 474-0170
Business address
7707 GATEWAY BLVD., SUITE 140, NEWARK, CA, 94560-1160
Former names
Protagonist Therapeutics Inc, Protagonist Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$26,552,861
in 2 filings, $26.6M under 10b5-1 plans

Net −$26,552,861. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. PATEL DINESH V PH D −$18.2M President and CEO sold 19% of stake
  2. Ali Asif −$8.3M Chief Financial Officer sold 50% of stake
Date Insider Transaction Shares Price Value Owned after
2017-04-06 PATEL DINESH V PH D President and CEO Option exercise +20,000 $1.16 $23K 171,338
2017-04-06 PATEL DINESH V PH D President and CEO Option exercise · Stock Option (right to buy) −20,000 97,302
2017-03-10 PATEL DINESH V PH D President and CEO Option exercise +16,362 $0.87 $14K 151,338
2017-03-10 PATEL DINESH V PH D President and CEO Option exercise · Stock Option (right to buy) −16,362 11,297
2016-10-11 PATEL DINESH V PH D President and CEO Grant or award · Stock Option (right to buy) +320,000 320,000
2016-10-11 Shames Richard S. Chief Medical Officer Grant or award · Stock Option (right to buy) +65,000 65,000
2016-10-11 O'Neil Thomas P. Chief Financial Officer Grant or award · Stock Option (right to buy) +45,000 45,000
2016-10-11 Liu David Y Chief Scientific Officer Grant or award · Stock Option (right to buy) +65,000 65,000
2016-10-11 HODDER WILLIAM A Sr. VP - Corporate Development Grant or award · Stock Option (right to buy) +65,000 65,000
2016-09-13 KHOSLA CHAITAN PHD Director Grant or award · Stock Option (right to buy) +5,000 5,000
2016-09-13 Waddill William D. Director Grant or award · Stock Option (right to buy) +24,000 24,000
2016-09-13 Shanafelt Armen Director Grant or award · Stock Option (right to buy) +24,000 24,000
2016-09-13 SELICK HAROLD E Director Grant or award · Stock Option (right to buy) +24,000 24,000
2016-09-13 KHOSLA CHAITAN PHD Director Grant or award · Stock Option (right to buy) +24,000 24,000
2016-09-13 Papanek Julie Director Grant or award · Stock Option (right to buy) +24,000 24,000
2016-08-16 JOHNSON & JOHNSON 10% owner Conversion +965,517 965,517
2016-08-16 JOHNSON & JOHNSON 10% owner Conversion +900,333 1,865,850
2016-08-16 JOHNSON & JOHNSON 10% owner Purchase +583,333 $12.00 $7.0M 2,449,183
2016-08-16 JOHNSON & JOHNSON 10% owner Conversion · Series B Preferred Stock −14,000,000 0
2016-08-16 JOHNSON & JOHNSON 10% owner Conversion · Series C Preferred Stock −13,054,830 0

Page 28 of 29 · 580 trades